<p>According to reports, Iskra Reic, the newly appointed Global Executive Vice President and Head of International Business at AstraZeneca, announced in an internal letter that Lin Xiao has been appointed General Manager of AstraZeneca China, and Guan Dongmei has been appointed General Manager of AstraZeneca China Oncology Business. Lin Xiao and Guan Dongmei will respectively become members of the global management teams for the Biopharmaceuticals and Oncology Business Units. Lin Xiao, Guan Dongmei, and Hu Yiqing, Vice President of AstraZeneca China and Head of the Rare Disease Division, will all report directly to Iskra Reic</p>

<p>AstraZeneca announced personnel changes, with Lin Xiao appointed as General Manager of AstraZeneca China, and Guan Dongmei serving as General Manager of the China Oncology Business. Both will become members of the global management team for the biopharmaceutical and oncology business and will report directly to Global Executive Vice President Iskra Reic</p>

AstraZeneca China personnel adjustment: Lin Xiao appointed as General Manager of AstraZeneca China